Ōura Ring to Integrate Blood Pressure Monitoring Following FDA Policy Shift

MedTech Dive USA

Overview

The Ōura smart ring is set to roll out new health and wellness features in June, including a tool for tracking nocturnal blood pressure patterns, following a policy change by the FDA. This feature aims to show trends in nighttime blood pressure variations and their correlation with daily habits like sleep, stress, and exercise. The FDA’s evolving stance on digital health technologies, which distinguishes between informational tools and regulated medical devices, facilitates the introduction of such non-diagnostic monitoring functionalities.

In Depth

Background: Rising Wearables and Evolving FDA Regulations

Wearable devices have rapidly evolved from basic fitness trackers to sophisticated health monitors. In response, the U.S. Food and Drug Administration (FDA) has been refining its regulatory approach based on the nature of the information these devices provide. Notably, the FDA is shifting towards a more lenient stance for wellness devices that primarily offer information for self-management rather than directly diagnosing or treating conditions. This policy evolution is empowering devices like the Ōura Ring to integrate new physiological monitoring capabilities.

Ōura Ring’s New Features: Nocturnal Blood Pressure and Respiratory Tracking

Following the launch of its latest smart ring, Ōura plans to deploy several new health and wellness features in June 2026. A standout addition is a tool designed to track nocturnal blood pressure patterns. Ōura specifies that this blood pressure function aims to illustrate trends in nighttime variations and their relationships with daily habits such as sleep, stress levels, and physical activity. Additionally, the update will include a feature to display 30-day nocturnal respiratory data, such as breathing rate. These functionalities are intended for trend analysis and self-management insights, not for medical diagnosis or treatment.

Industry Impact and Future Outlook

The introduction of nocturnal blood pressure tracking by the Ōura Ring is expected to intensify competition in the wearable market and provide users with new opportunities to better understand their health data and drive lifestyle improvements. The FDA’s adaptive regulatory framework facilitates the market entry of innovative digital health technologies, allowing companies to deploy new features more swiftly. However, balancing accuracy and appropriate user communication remains paramount. In the future, data collected by such wellness devices could contribute not only to individual health enhancement but also to broader public health data, significantly advancing personalized healthcare.